Homozygous C3 deficiency: detection of C3 by radioimmunoassay. 1977

A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper

UI MeSH Term Description Entries
D007104 Immune Adherence Reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Adherence Reaction, Immune,Adherence Reactions, Immune,Immune Adherence Reactions,Reaction, Immune Adherence,Reactions, Immune Adherence
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3

Related Publications

A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
August 2017, Indian journal of pediatrics,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
January 1991, Nephron,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
July 2002, Indian journal of pediatrics,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
January 1977, British journal of haematology,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
December 1972, Lancet (London, England),
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
November 2002, Journal of clinical immunology,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
June 1992, Proceedings of the National Academy of Sciences of the United States of America,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
November 2005, American journal of medical genetics. Part A,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
November 2013, CEN case reports,
A E Davis, and J S Davis, and A R Rabson, and S G Osofsky, and H R Colten, and F S Rosen, and C A Alper
January 2000, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!